Cargando…
Overexpression and Selective Anticancer Efficacy of ENO3 in STK11 Mutant Lung Cancers
Oncogenic gain-of-function mutations are clinical biomarkers for most targeted therapies, as well as represent direct targets for drug treatment. Although loss-of-function mutations involving the tumor suppressor gene, STK11 (LKB1) are important in lung cancer progression, STK11 is not the direct ta...
Autores principales: | Park, Choa, Lee, Yejin, Je, Soyeon, Chang, Shengzhi, Kim, Nayoung, Jeong, Euna, Yoon, Sukjoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883975/ https://www.ncbi.nlm.nih.gov/pubmed/31697874 http://dx.doi.org/10.14348/molcells.2019.0099 |
Ejemplares similares
-
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer
por: Kim, Nayoung, et al.
Publicado: (2016) -
QSurface: fast identification of surface expression markers in cancers
por: Hong, Yourae, et al.
Publicado: (2018) -
Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
por: Jeong, Euna, et al.
Publicado: (2020) -
Dissecting phenotypic responses of the druggable targetome in cancers
por: Jeong, Euna, et al.
Publicado: (2019) -
Glucose starvation induces mutation and lineage-dependent adaptive responses in a large collection of cancer cell lines
por: HE, NINGNING, et al.
Publicado: (2015)